Researchers find that tiny doses of lithium could slow Alzheimer’s symptoms by reducing brain plaques and protecting neural ...

Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...

The drug is called Leqembi, and it removes plaques in the brain that are associated with Alzheimer's. After about 18 months, ...

A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the ...

People with Alzheimer’s disease have lower levels of lithium in their brains than those without cognitive impairment, and the ...

Differences in outcomes between patients with early Alzheimer’s disease who used lecanemab and matched controls increased ...

A new drug cleared 91% of brain amyloid plaques in 7 months, showing faster results than current Alzheimer's treatments and advancing to Phase III trials in 2025.

“Our study complements these findings by showing, for the first time, that more intensive lifestyle changes may often stop or ...

In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months ...

New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.